Structure-based drug design
- 31 December 1994
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Structural Biology
- Vol. 4 (6), 868-874
- https://doi.org/10.1016/0959-440x(94)90268-2
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Structure-based drug design: progress, results and challengesStructure, 1994
- X-ray Crystallographic Studies of a Series of Penicillin-Derived Asymmetric Inhibitors of HIV-1 ProteaseBiochemistry, 1994
- Drug-DNA interactionsCurrent Opinion in Structural Biology, 1994
- Structure-Based Molecular DesignAccounts of Chemical Research, 1994
- Application of the Three-Dimensional Structures of Protein Target Molecules in Structure-Based Drug DesignJournal of Medicinal Chemistry, 1994
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- HIV protease-ligand complexes: Current Opinion in Structural Biology 1993, 3: 868–874Current Opinion in Structural Biology, 1993
- Pharmacologically relevant proteinsCurrent Opinion in Structural Biology, 1993
- Orientational sampling and rigid‐body minimization in molecular dockingProteins-Structure Function and Bioinformatics, 1993
- Structure-based drug design: applications in immunopharmacology and immunosuppressionTrends in Pharmacological Sciences, 1993